基本信息
浏览量:8
职业迁徙
个人简介
She has dedicated her career to leading clinical and angiographic evaluations of more than 500 clinical trials in a broad range of ischemic cardiovascular therapeutic areas, including pharmacologic and interventional device trials, many of which are landmark trials in the field and/or leading to FDA approval in the United States. She has served as the principal investigator on numerous national and international imaging studies, device, DES and neuroprotection trials. Dr. Lansky has authored and coauthored over 500 academic peer-reviewed manuscripts in the fields of interventional cardiology, angiography, and women’s cardiovascular health. She chaired the American Heart Association Statement on Interventions in Women and most recently the Academic Research Consortium defining Neurologic Endpoints in clinical cardiovascular trials.
研究兴趣
论文共 1295 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
International journal of cardiology (2024): 131643-131643
Cardiovascular Revascularization Medicine (2024): 3-8
引用0浏览0引用
0
0
Journal of the American Heart Associationno. 2 (2024): e031111-e031111
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2024)
Trialsno. 1 (2024): 80-80
European Journal of Vascular and Endovascular Surgeryno. 2 (2024): e22-e23
Circulation. Cardiovascular quality and outcomesno. 1 (2024): e010200-e010200
Yousuf Shah,Tayyab Shah, Andrew Schwartz, Kanhaiya Poddar, William O'Neill,Mark Anderson,David Wohns,Perwaiz Meraj,Igor Palacios, Navin Kapur, Ali Almedhychy,Alexandra Lansky
Journal of Cardiac Failureno. 1 (2024): 269
The American journal of cardiology (2024): 94-101
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn